VivoSim Labs (FRA:4OR) Shiller PE Ratio: (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4OR VivoSim Labs Inc FRA:4OR
33 GF Score
Price €3.49
GF Value €15.21
! 6 Warning Signs
View Full Analysis

What is VivoSim Labs Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


VivoSim Labs  (FRA:4OR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


VivoSim Labs Shiller PE Ratio Related Terms


VivoSim Labs Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for VivoSim Labs's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VivoSim Labs Shiller PE Ratio Chart

VivoSim Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VivoSim Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:4OR vs SLXN, CDT, CLDI: Shiller PE Ratio Comparison

For the Biotechnology subindustry, VivoSim Labs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VivoSim Labs Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VivoSim Labs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where VivoSim Labs's Shiller PE Ratio falls into.


FRA:4OR
33GF Score
VivoSim Labs Inc FRA:4OR
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VivoSim Labs Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

VivoSim Labs's E10 for the quarter that ended in Mar. 2026 is calculated as:

For example, VivoSim Labs's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.912/330.2130*330.2130
=-1.912

Current CPI (Mar. 2026) = 330.2130.

VivoSim Labs Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201606 -19.224 241.018 -26.338
201609 -21.384 241.428 -29.248
201612 -20.477 241.432 -28.007
201703 -22.440 243.801 -30.394
201706 -21.360 244.955 -28.794
201709 -18.122 246.819 -24.245
201712 -14.196 246.524 -19.015
201803 -13.625 249.554 -18.029
201806 -14.381 251.989 -18.845
201809 -10.284 252.439 -13.452
201812 -12.658 251.233 -16.637
201903 -12.744 254.202 -16.555
201906 -10.620 256.143 -13.691
201909 -10.896 256.759 -14.013
201912 -6.480 256.974 -8.327
202003 -4.344 258.115 -5.557
202006 -4.262 257.797 -5.459
202009 -13.856 260.280 -17.579
202012 -3.650 260.474 -4.627
202103 -3.024 264.877 -3.770
202106 -2.888 271.696 -3.510
202109 -4.080 274.310 -4.911
202112 -4.248 278.802 -5.031
202203 -2.397 287.504 -2.753
202206 -4.200 296.311 -4.681
202209 -4.606 296.808 -5.124
202212 -4.191 296.797 -4.663
202303 -9.527 301.836 -10.423
202306 -5.095 305.109 -5.514
202309 -5.172 307.789 -5.549
202312 -4.402 306.746 -4.739
202403 -3.248 312.332 -3.434
202406 -2.545 314.175 -2.675
202409 -1.514 315.301 -1.586
202412 -2.177 315.605 -2.278
202503 4.532 319.799 4.680
202506 -0.988 322.561 -1.011
202509 -0.835 324.800 -0.849
202512 -0.880 324.054 -0.897
202603 -1.912 330.213 -1.912

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is VivoSim Labs (FRA:4OR) Overvalued in 2026?

Based on GuruFocus' analysis, VivoSim Labs stock appears to be undervalued. The current stock price of €3.49 is trading 77% below its estimated GF Value™ of €15.21.

Key valuation signals for FRA:4OR:

  • Shiller PE Ratio:
  • GF Value™: €15.21 vs. price of €3.49 (77% below fair value)
  • GF Score™: 33/100 with 6 warning signs

No single metric tells the full story. See the FRA:4OR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


VivoSim Labs Business Description

Other Exchanges VIVS:USA
Address 11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
33GF Score

Get the complete analysis for FRA:4OR

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.49
Price
€15.21
GF Value